These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28406926)

  • 21. Defective mitochondrial disulfide relay system, altered mitochondrial morphology and function in Huntington's disease.
    Napoli E; Wong S; Hung C; Ross-Inta C; Bomdica P; Giulivi C
    Hum Mol Genet; 2013 Mar; 22(5):989-1004. PubMed ID: 23197653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease.
    Siddiqui A; Rivera-Sánchez S; Castro Mdel R; Acevedo-Torres K; Rane A; Torres-Ramos CA; Nicholls DG; Andersen JK; Ayala-Torres S
    Free Radic Biol Med; 2012 Oct; 53(7):1478-88. PubMed ID: 22709585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease.
    Saft C; Zange J; Andrich J; Müller K; Lindenberg K; Landwehrmeyer B; Vorgerd M; Kraus PH; Przuntek H; Schöls L
    Mov Disord; 2005 Jun; 20(6):674-9. PubMed ID: 15704211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice.
    Oliveira JM; Jekabsons MB; Chen S; Lin A; Rego AC; Gonçalves J; Ellerby LM; Nicholls DG
    J Neurochem; 2007 Apr; 101(1):241-9. PubMed ID: 17394466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetyl-CoA-driven respiration in frozen muscle contributes to the diagnosis of mitochondrial disease.
    Zuccolotto-Dos-Reis FH; Escarso SHA; Araujo JS; Espreafico EM; Alberici LC; Sobreira CFDR
    Eur J Clin Invest; 2021 Sep; 51(9):e13574. PubMed ID: 33937992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
    Aladdin A; Király R; Boto P; Regdon Z; Tar K
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.
    Kuhn A; Goldstein DR; Hodges A; Strand AD; Sengstag T; Kooperberg C; Becanovic K; Pouladi MA; Sathasivam K; Cha JH; Hannan AJ; Hayden MR; Leavitt BR; Dunnett SB; Ferrante RJ; Albin R; Shelbourne P; Delorenzi M; Augood SJ; Faull RL; Olson JM; Bates GP; Jones L; Luthi-Carter R
    Hum Mol Genet; 2007 Aug; 16(15):1845-61. PubMed ID: 17519223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The C57Bl/6 mouse serves as a suitable model of human skeletal muscle mitochondrial function.
    Jacobs RA; Díaz V; Meinild AK; Gassmann M; Lundby C
    Exp Physiol; 2013 Apr; 98(4):908-21. PubMed ID: 23180810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.
    Shirendeb U; Reddy AP; Manczak M; Calkins MJ; Mao P; Tagle DA; Reddy PH
    Hum Mol Genet; 2011 Apr; 20(7):1438-55. PubMed ID: 21257639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.
    Haun F; Nakamura T; Shiu AD; Cho DH; Tsunemi T; Holland EA; La Spada AR; Lipton SA
    Antioxid Redox Signal; 2013 Oct; 19(11):1173-84. PubMed ID: 23641925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A genetic modifier suggests that endurance exercise exacerbates Huntington's disease.
    Corrochano S; Blanco G; Williams D; Wettstein J; Simon M; Kumar S; Moir L; Agnew T; Stewart M; Landman A; Kotiadis VN; Duchen MR; Wackerhage H; Rubinsztein DC; Brown SDM; Acevedo-Arozena A
    Hum Mol Genet; 2018 May; 27(10):1723-1731. PubMed ID: 29509900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal Mutant Huntingtin Protein Levels Decline with Age in Homozygous Huntington's Disease Knock-In Mouse Models.
    Franich NR; Basso M; André EA; Ochaba J; Kumar A; Thein S; Fote G; Kachemov M; Lau AL; Yeung SY; Osmand A; Zeitlin SO; Ratan RR; Thompson LM; Steffan JS
    J Huntingtons Dis; 2018; 7(2):137-150. PubMed ID: 29843246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role of mitochondrial complex II defects in genetic models of Huntington's disease expressing N-terminal fragments of mutant huntingtin.
    Damiano M; Diguet E; Malgorn C; D'Aurelio M; Galvan L; Petit F; Benhaim L; Guillermier M; Houitte D; Dufour N; Hantraye P; Canals JM; Alberch J; Delzescaux T; Déglon N; Beal MF; Brouillet E
    Hum Mol Genet; 2013 Oct; 22(19):3869-82. PubMed ID: 23720495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of mutant and total huntingtin expression in Huntington's disease murine models.
    Fodale V; Pintauro R; Daldin M; Altobelli R; Spiezia MC; Bisbocci M; Macdonald D; Bresciani A
    Sci Rep; 2020 Dec; 10(1):22137. PubMed ID: 33335120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA methylation study of Huntington's disease and motor progression in patients and in animal models.
    Lu AT; Narayan P; Grant MJ; Langfelder P; Wang N; Kwak S; Wilkinson H; Chen RZ; Chen J; Simon Bawden C; Rudiger SR; Ciosi M; Chatzi A; Maxwell A; Hore TA; Aaronson J; Rosinski J; Preiss A; Vogt TF; Coppola G; Monckton D; Snell RG; William Yang X; Horvath S
    Nat Commun; 2020 Sep; 11(1):4529. PubMed ID: 32913184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of in vivo skeletal muscle mitochondrial respiratory capacity in humans by near-infrared spectroscopy: a comparison with in situ measurements.
    Ryan TE; Brophy P; Lin CT; Hickner RC; Neufer PD
    J Physiol; 2014 Aug; 592(15):3231-41. PubMed ID: 24951618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers.
    Silva AC; Almeida S; Laço M; Duarte AI; Domingues J; Oliveira CR; Januário C; Rego AC
    Mitochondrion; 2013 Nov; 13(6):801-9. PubMed ID: 23707479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.
    Oliveira JM
    J Neurochem; 2010 Jul; 114(1):1-12. PubMed ID: 20403078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial Respiration Changes in R6/2 Huntington's Disease Model Mice during Aging in a Brain Region Specific Manner.
    Burtscher J; Di Pardo A; Maglione V; Schwarzer C; Squitieri F
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta catenin is regulated by its subcellular distribution and mutant huntingtin status in Huntington's disease cell STHdhQ111/HdhQ111.
    Ghatak S; Raha S
    Biochem Biophys Res Commun; 2018 Sep; 503(1):359-364. PubMed ID: 29894684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.